Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of Sealed Air Corporation's proposed sale to CD&R for $42.15 per share, which is below the price targets set by at least two Wall Street analysts [1][3]. Group 1: Sale Details - Sealed Air announced an agreement to be sold to CD&R for $42.15 per share in cash on November 17, 2025 [3]. - The proposed sale price is lower than the price targets of $46.00 and $45.00 per share set by analysts Gabriel Hajde of Wells Fargo and Michael Roxland of Truist Financial, respectively [3]. Group 2: Investigation Purpose - The investigation aims to determine if the Sealed Air Board of Directors acted in the best interests of shareholders when approving the sale [4]. - It will assess whether the agreed price is fair to shareholders and if all material information regarding the transaction has been fully disclosed [4].

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the sale of scPharmaceuticals, Inc. to MannKind Corporation for $5.35 per share in cash, plus a contingent value right offering milestone-based payments of up to $1.00 per share [1][3]. Summary by Relevant Sections Sale Details - scPharmaceuticals, Inc. has agreed to be sold to MannKind Corporation for $5.35 per share in cash, along with a non-tradable contingent value right that offers milestone-based payments of up to $1.00 per share [1][3]. Price Evaluation - The sales price of $5.35 per share is below the price targets set by multiple Wall Street analysts prior to the announcement, indicating potential undervaluation [2][3]. - Analysts' price targets include $25.00 by TD Cowen, $18.00 by H.C. Wainwright, $13.00 by Jefferies, and $12.00 by Craig-Hallum [5]. Investigation Rationale - The investigation aims to determine whether the SCPH Board of Directors acted in the best interests of shareholders and if the agreed price is fair, along with the completeness of material information disclosed regarding the transaction [3].

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of WK Kellogg Co. to Ferrero Group for $23.00 per share in cash, following concerns raised by investors regarding the sale price [1][2]. Group 1: Sale Details - Kellogg announced an agreement to be sold to Ferrero Group for $23.00 per share in cash on July 10, 2025 [2]. - At least one investor has publicly expressed disappointment with the sale price, claiming that shareholders are being unfairly treated [2]. Group 2: Investigation Purpose - The investigation aims to determine if the Kellogg Board of Directors acted in the best interests of shareholders when approving the sale [2]. - The inquiry will assess whether the agreed price is fair and if all material information regarding the transaction has been fully disclosed [2]. Group 3: Firm Background - Wohl & Fruchter LLP has over a decade of experience representing investors in litigation related to fraud and corporate misconduct, recovering hundreds of millions of dollars for investors [3].